NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
Titel:
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
Auteur:
Wainberg, Zev A Melisi, Davide Macarulla, Teresa Pazo Cid, Roberto Chandana, Sreenivasa R De La Fouchardière, Christelle Dean, Andrew Kiss, Igor Lee, Woo Jin Goetze, Thorsten O Van Cutsem, Eric Paulson, A Scott Bekaii-Saab, Tanios Pant, Shubham Hubner, Richard A Xiao, Zhimin Chen, Huanyu Benzaghou, Fawzi O'Reilly, Eileen M
Verschenen in:
Lancet
Paginering:
Jaargang 402 () nr. 10409 pagina's 1272-1281
Jaar:
2023
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license